AdaptHealth Sells Diabetes Unit to Cardinal Health for $235M Cash
AHCO sits 31% above its 52-week low of $8.505.
Summary
AdaptHealth is selling its Diabetes Health business to Cardinal Health for $235 million in cash. The deal provides a significant cash infusion for a company that reported negative free cash flow and a wider net loss in Q1 2026, and recently disclosed a material cybersecurity incident. This follows the redemption of $325 million in senior notes earlier this month, suggesting a broader effort to strengthen the balance sheet. The sale price represents about 16% of AdaptHealth's market cap, making it a material divestiture. The transaction is expected to close in the coming months, subject to customary conditions.
At the time of this announcement, AHCO was trading at $11.17 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $1.5B. The 52-week trading range was $8.51 to $13.43. This news item was assessed with positive market sentiment and an importance score of 8 out of 10. Source: Dow Jones Newswires.